STOUT JAY S (Chief Technology Officer) sold 1.9% of their position (3.81K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $122.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/9/2026ACC: 0001702969-26-000012
Officer· Chief Technology Officer
Since Apr 2023
-3.81K
Net shares
Net seller
$122.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.81K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.21K
Price / share
$32.06
Trade value
$70.95K
% of position
1.1%
10/7/2026
205.34K→203.13K
Common Stock
Direct
Shares
−1.60K
Price / share
$32.06
Trade value
$51.17K
% of position
0.8%
10/7/2026
203.13K→201.53K
Total
Net shares
−3.81K
Net value
-$122.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/7/2026 | S · Sale | −2.21K | $32.06 | $70.95K | 1.1% | 205.34K | 203.13K |
| Common Stock Direct | 10/7/2026 | S · Sale | −1.60K | $32.06 | $51.17K | 0.8% | 203.13K | 201.53K |
| Total | −3.81K | -$122.12K | ||||||
Derivative Transactions0
No derivative transactions reported